Bionote announced that the outstanding performance of its Vcheck SDMA has been validated in a recent study published in the SCI-indexed American Journal of Veterinary Research.

The study revealed that Vcheck SDMA showed a strong correlation (r = 0.93) with laboratory-based reference SDMA results and outperformed other point-of-care (POC) analyzers in consistency and reliability. These findings highlight the test’s robustness and practical utility for in-clinic use.

Importantly, when Vcheck SDMA results were applied to IRIS guidelines for chronic kidney disease (CKD) staging, the test achieved a 93% agreement with reference laboratory staging—the highest among all POC SDMA analyzers evaluated in the study.

To access the full article, click [here], or click [here] to view a summary of the findings.

The Vcheck SDMA 2.0 kit, launched in Q2 of 2025, continues to offer a streamlined testing workflow with trusted analytical performance. 

For product information or availability, please contact your regional manager.